Return to homepagePandemic Pact

Harnessing T cell immunity to boost vaccine efficacy

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA201518

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022
    2026

  • Known Financial Commitments (USD)

    $952,069.22

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Research Location

    Australia

  • Lead Research Institution

    University of Melbourne

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Characterisation of vaccine-induced immunity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The recent SARS-CoV-2 pandemic has highlighted the need for rapid, large-scale vaccine development. This research program will study how specific types of T cells can be activated in order to improve the immune response to vaccines, with the goal of identifying new vaccine platforms that can be successfully deployed in future pandemics. This work will advance our knowledge of vaccine-related immunology and significantly improve human health.